title: [TSH secretion stimulated by thyroliberin in patients with hypothyroidism receiving 1,25-hydroxyvitamin D3].
abstract: The effect of 1,25-hydroxy vitamin D3 on the secretion of TSH was studied in 49 patients with primary hypothyroidism. The vitamin D3 metabolite did not cause any significant changes in the secretion of TSH both basal and stimulated with TRH in patients with untreated hypothyroidism. In those treated with the synthetic L-thyroxine it produced a significant increase in basal TSH secretion.
authors.affiliation: I Klinika Chorób Wewnetrznych Slaskiej AM, Katowicach.
authors.forename: T
authors.initials: T
authors.lastname: Gasińska
authors.forename: A
authors.initials: A
authors.lastname: Kierat
authors.forename: A
authors.initials: A
authors.lastname: Kochańska-Dziurowicz
authors.forename: M
authors.initials: M
authors.lastname: Izbicka
mesh_terms: D002112:Calcifediol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D013972:Thyrotropin / Q000187:drug effects / Q000378:metabolism*; D013973:Thyrotropin-Releasing Hormone; D013974:Thyroxine / Q000627:therapeutic use
chemical_list: D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D002112:Calcifediol; D013974:Thyroxine
vernacular_title: Sekrecja TSH stymulowana tyreoliberyna u chorych z niedoczynnościa tarczycy otrzymujacych 1,25 (OH)2 witamine D3.